Abbott Laboratories (ABT)
Abbott Laboratories (ABT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 12,593 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10,143 | 10,241 | 9,964 | 10,377 | 10,635 | 10,974 | 10,358 | 11,142 | 11,369 | 11,459 | 11,164 | 12,593 | 46,585 | |
| 5,109 | 4,983 | 4,942 | 5,072 | 5,209 | 5,376 | 4,914 | 4,854 | 5,031 | 4,922 | 4,881 | 5,289 | 20,123 | |
| 5,034 | 5,258 | 5,022 | 5,305 | 5,426 | 5,598 | 5,444 | 6,288 | 6,338 | 6,537 | 6,283 | 7,304 | 26,462 | |
| 661 | 690 | 683 | 697 | 713 | 728 | 703 | 732 | 785 | 735 | 756 | 882 | 3,158 | |
| 2,680 | 2,724 | 2,959 | 2,936 | 2,895 | 2,907 | 3,061 | 3,090 | 3,051 | 3,129 | 3,740 | – | – | |
| 3,356 | 3,394 | 3,637 | 3,619 | 3,608 | 3,608 | 3,756 | 4,236 | 4,308 | 4,286 | 4,441 | 5,522 | 18,557 | |
| 1,678 | 1,864 | 1,385 | 1,686 | 1,818 | 1,990 | 1,688 | 2,052 | 2,057 | 2,251 | 1,842 | 1,782 | 7,932 | |
| 148 | 235 | 117 | 168 | 166 | 152 | 134 | 121 | 44 | 120 | 174 | 299 | 637 | |
| 1,671 | 1,795 | 1,436 | 1,607 | 1,940 | 2,030 | 1,778 | 2,150 | 2,180 | 2,358 | 1,449 | 1,524 | 7,511 | |
| 235 | 201 | 211 | 305 | 294 | -7,199 | 453 | 371 | 536 | 582 | 372 | 596 | 2,086 | |
| 1,436 | 1,594 | 1,225 | 1,302 | 1,646 | 9,229 | 1,325 | 1,779 | 1,644 | 1,776 | 1,077 | 928 | 5,425 | |
| 2,643 | 2,843 | 2,358 | 2,580 | 2,907 | 2,989 | 2,668 | 3,048 | 3,092 | 2,822 | 2,247 | 1,782 | 9,943 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.